Medivation Technologies, Inc.
Records under this name other than the patents Medivation Technologies, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 19 patents it holds.
Back to Medivation Technologies, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,541,403 | Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency Lapsed on the fee record Ended Sep 24, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 24, 2025 | From the USPTO record |
| US 10,493,078 | Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency Lapsed on the fee record Ended Dec 3, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 3, 2023 | From the USPTO record |
| US 9,018,201 | Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency Lapsed on the fee record Ended Apr 28, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 28, 2023 | From the USPTO record |
| US 10,189,826 | Heterocyclic compounds and methods of use Lapsed on the fee record Ended Jan 29, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jan 29, 2023 | From the USPTO record |
| US 10,183,015 | Heterocyclic compounds and methods of use Lapsed on the fee record Ended Jan 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jan 22, 2023 | From the USPTO record |
| US 9,670,172 | Heterocyclic compounds and methods of use Lapsed on the fee record Ended Jun 6, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jun 6, 2021 | From the USPTO record |
| US 9,580,425 | Pyrido[3,4-b] indoles and methods of use Lapsed on the fee record Ended Feb 28, 2021 · From the USPTO record | Lapsed on the fee record | Ended Feb 28, 2021 | From the USPTO record |
| US 9,527,854 | Compounds and methods for treatment of hypertension Lapsed on the fee record Ended Dec 27, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 27, 2020 | From the USPTO record |
| US 8,338,408 | Tetracyclic compounds Lapsed on the fee record Ended Dec 25, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 25, 2020 | From the USPTO record |
| US 8,338,447 | Pyrido[3,4-B]indoles and methods of use Lapsed on the fee record Ended Dec 25, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 25, 2020 | From the USPTO record |